1. Köhler-Forsberg O, Stiglbauer V, Brasanac J, Chae WR, Wagener F, Zimbalski K, et al. Efficacy and Safety of Antidepressants in Patients With Comorbid Depression and Medical Diseases: An Umbrella Systematic Review and Meta-Analysis. JAMA Psychiatry. 2023 Dec 1;80(12):1196.
2. Kim HK, Blumberger DM, Fitzgerald PB, Mulsant BH, Daskalakis ZJ. Antidepressant treatment outcomes in patients with and without comorbid physical or psychiatric disorders: A systematic review and meta-analysis. J Affect Disord. 2021 Dec;295:225–34.
3. Arnaud AM, Brister TS, Duckworth K, Foxworth P, Fulwider T, Suthoff ED, et al. Impact of Treating Depression on Associated Comorbidities: A Systematic Literature Review. Prim Care Companion CNS Disord. 2023.
4. Ma Y, Xiang Q, Yan C, Liao H, Wang J. Relationship between chronic diseases and depression: the mediating effect of pain. BMC Psychiatry. 2021 Sep 6;21:436.
5. Low Y, Setia S, Lima G. Drug–drug interactions involving antidepressants: focus on desvenlafaxine. Neuropsychiatr Dis Treat. 2018 Feb 19;14:567–80.
6. Shin J, Hills NK, Finley PR. Combining Antidepressants with β-Blockers: Evidence of a Clinically Significant CYP2D6 Drug Interaction. Pharmacotherapy. 2020 Jun;40(6):507–16.
7. Gagnon J, Lussier MT, MacGibbon B, Daskalopoulou SS, Bartlett G. The Impact of Antidepressant Therapy on Glycemic Control in Canadian Primary Care Patients With Diabetes Mellitus. Front Nutr. 2018 Jun 12;5:47. doi: 10.3389/fnut.2018.00047.
8. Edinoff AN, Raveendran K, Colon MA, Thomas BH, Trettin KA, Hunt GW, et al. Selective Serotonin Reuptake Inhibitors and Associated Bleeding Risks: A Narrative and Clinical Review. Health Psychol Res. 2022;10(4):39580.
9. Gregg A. Robbins-Welty MD, Andrew N. Tuck MD, Dale Marchant F, Andrew Gleason F, Richard Garrett Key MD, Barbara Lubrano Di Ciccone MD, et al. Bleeding Risk With SSRIs, Part 1: Cardiovascular and Cerebrovascular Considerations. 2023.
10. Craig DP, Osborne C. Risk of seizures with antidepressants: what is the evidence? Drug Ther Bull. 2020 Sep 1;58(9):137–40.